Bruxism of bruxism. Examples include the "Bruxcore Bruxism-Monitoring Device" (BBMD, "Bruxcore Plate"), the "intra-splint force detector" (ISFD), and electromyographic devices to measure masseter or temporalis muscle activity (e.g. the "BiteStrip", and the "Grindcare"). The ICSD-R listed diagnostic criteria for sleep bruxism. The minimal criteria include both of the following: With the following criteria supporting the diagnosis: "Bruxism" is derived from the Greek word ("brykein") "to bite, "or" to gnash, grind the teeth". People who suffer from bruxism are called "bruxists" or "bruxers" and the verb itself is "to brux". There is no widely accepted definition of bruxism. Examples of definitions include:
Bruxism there is only one randomized control trial which has reported that Botox reduces the myofascial pain symptoms. This scientific study was based on thirty people with bruxism who received Botox injections into the muscles of mastication and a control group of people with bruxism who received placebo injections. Normally multiple trials with larger cohorts are required to make any firm statement about the efficacy of a treatment. In 2013, a further randomized control trial investigating Botox in bruxism started. There is also little information available about the safety and long term followup of this treatment for bruxism. Botulinum toxin causes